Spots Global Cancer Trial Database for myeloid neoplasm
Every month we try and update this database with for myeloid neoplasm cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Reduced-Intensity Conditioning for the Prevention of Treatment-Related Mortality in Patients Who Undergo a Hematopoietic Stem Cell Transplant | NCT05031897 | Acute Lymphobla... Acute Myeloid L... Aplastic Anemia Chronic Lymphoc... Chronic Myelomo... Essential Throm... Hematopoietic a... Hodgkin Lymphom... Myelodysplastic... Myelofibrosis Myeloid Leukemi... Myeloid Neoplas... Non-Hodgkin Lym... Plasma Cell Mye... Polycythemia Ve... Small Lymphocyt... | Hematopoietic C... Mycophenolate M... Tacrolimus Cyclophosphamid... Total-Body Irra... Donor Lymphocyt... Fludarabine Melphalan | 18 Years - | Thomas Jefferson University | |
| CPX-351 Versus Immediate Stem Cell Transplantation for the Treatment of High-Grade Myeloid Cancers With Measurable Residual Disease | NCT04526288 | Acute Myeloid L... Myelodysplastic... Myeloid Neoplas... | Allogeneic Hema... Liposome-encaps... | 18 Years - | Fred Hutchinson Cancer Center | |
| A Pilot Study to Evaluate the Feasibility of Post-Hematopoietic Stem Cell Transplant Prophylaxis With Decitabine Combined With Filgrastim for Children and Young Adults With AML, MDS and Related Myeloid Malignancies | NCT05796570 | Acute Myeloid L... Myelodysplastic... Myeloid Maligna... MDS Inherited Bone ... Myeloid Neoplas... Aml | Decitabine Filgrastim | 1 Year - 39 Years | Dana-Farber Cancer Institute | |
| Study of CPX-351 (VYXEOS) in Individuals < 22 Years With Secondary Myeloid Neoplasms | NCT05656248 | Myeloid Neoplas... | CPX-351 MHA Allogeneic Hema... | 1 Year - 21 Years | St. Jude Children's Research Hospital | |
| A Pilot Study to Evaluate the Feasibility of Post-Hematopoietic Stem Cell Transplant Prophylaxis With Decitabine Combined With Filgrastim for Children and Young Adults With AML, MDS and Related Myeloid Malignancies | NCT05796570 | Acute Myeloid L... Myelodysplastic... Myeloid Maligna... MDS Inherited Bone ... Myeloid Neoplas... Aml | Decitabine Filgrastim | 1 Year - 39 Years | Dana-Farber Cancer Institute | |
| CPX-351 or CLAG-M Regimen for the Treatment of Acute Myeloid Leukemia or Other High-Grade Myeloid Neoplasms in Medically Less-Fit Patients | NCT04195945 | Acute Myeloid L... Myeloid Neoplas... | Liposome-encaps... Cladribine Cytarabine Recombinant Gra... Mitoxantrone Questionnaire A... Quality-of-Life... | 18 Years - | Fred Hutchinson Cancer Center | |
| Higher or Lower Dose Cladribine, Cytarabine, and Mitoxantrone in Treating Medically Less Fit Patients With Newly Diagnosed Acute Myeloid Leukemia or Myeloid Neoplasm | NCT03012672 | Acute Leukemia ... Acute Myeloid L... Myeloid Neoplas... | Cladribine Cytarabine Granulocyte Col... Mitoxantrone Hy... Quality-of-Life... Questionnaire A... | 18 Years - | University of Washington | |
| Higher or Lower Dose Cladribine, Cytarabine, and Mitoxantrone in Treating Medically Less Fit Patients With Newly Diagnosed Acute Myeloid Leukemia or Myeloid Neoplasm | NCT03012672 | Acute Leukemia ... Acute Myeloid L... Myeloid Neoplas... | Cladribine Cytarabine Granulocyte Col... Mitoxantrone Hy... Quality-of-Life... Questionnaire A... | 18 Years - | University of Washington | |
| DEC-C and Thioguanine for R/R AML | NCT06351306 | Acute Myeloid L... | Thioguanine (Ta... DecitabineCedaz... | 18 Years - | Columbia University | |
| A Randomized Trial of a Mobile Health Exercise Intervention for Older Adults With Myeloid Neoplasms | NCT04981821 | Cancer Myeloid Neoplas... | GO-EXCAP Mobile... Behavioral Plac... | 60 Years - | University of Rochester | |
| Bortezomib and Sorafenib Tosylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia | NCT01371981 | Acute Myeloid L... Leukemia Cutis Myeloid Neoplas... Myeloid Sarcoma | Asparaginase Bortezomib Cytarabine Daunorubicin Hy... Etoposide Laboratory Biom... Mitoxantrone Hy... Pharmacological... Quality-of-Life... Questionnaire A... Sorafenib Tosyl... | - 29 Years | National Cancer Institute (NCI) | |
| Chlorhexidine Gluconate Cleansing in Preventing Central Line Associated Bloodstream Infection and Acquisition of Multi-drug Resistant Organisms in Younger Patients With Cancer or Undergoing Donor Stem Cell Transplant | NCT01817075 | Bacterial Infec... Benign Neoplasm Malignant Neopl... Methicillin-Res... Myeloid Neoplas... Recurrent Child... Recurrent Child... | Chlorhexidine G... Laboratory Biom... Mild Soap Skin ... Questionnaire A... | 2 Months - 21 Years | Children's Oncology Group | |
| Tyrosine Kinase Inhibition to Treat Myeloid Hypereosinophilic Syndrome | NCT00044304 | Eosinophilic My... Hypereosinophil... | Imatinib Ruxolitinib | 2 Years - | National Institutes of Health Clinical Center (CC) | |
| Futibatinib in Patients With Specific FGFR Aberrations | NCT04189445 | Advanced or Met... Advanced or Met... Myeloid or Lymp... | Futibatinib | 18 Years - | Taiho Oncology, Inc. | |
| Caspofungin Versus Fluconazole in Preventing Invasive Fungal Infections (IFI) in Patients Undergoing Chemotherapy for Acute Myeloid Leukemia | NCT01307579 | Acute Myeloid L... Adult Acute Mon... Adult Acute Mon... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Alkylating Agen... Childhood Acute... Childhood Acute... Childhood Acute... Childhood Acute... Childhood Acute... Childhood Acute... Childhood Acute... Fungal Infectio... Myeloid Neoplas... Neutropenia Recurrent Adult... Recurrent Child... Secondary Acute... Untreated Adult... Untreated Child... | Caspofungin Ace... Fluconazole Laboratory Biom... | 3 Months - 30 Years | Children's Oncology Group | |
| Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Promyelocytic Leukemia | NCT00866918 | Childhood Acute... Myeloid Neoplas... | Arsenic Trioxid... Cytarabine Diagnostic Labo... Idarubicin Mercaptopurine Methotrexate Mitoxantrone Hy... Tretinoin | 2 Years - 21 Years | Children's Oncology Group | |
| DEC-C and Thioguanine for R/R AML | NCT06351306 | Acute Myeloid L... | Thioguanine (Ta... DecitabineCedaz... | 18 Years - | Columbia University | |
| Tyrosine Kinase Inhibition to Treat Myeloid Hypereosinophilic Syndrome | NCT00044304 | Eosinophilic My... Hypereosinophil... | Imatinib Ruxolitinib | 2 Years - | National Institutes of Health Clinical Center (CC) | |
| Reduced-Intensity Conditioning for the Prevention of Treatment-Related Mortality in Patients Who Undergo a Hematopoietic Stem Cell Transplant | NCT05031897 | Acute Lymphobla... Acute Myeloid L... Aplastic Anemia Chronic Lymphoc... Chronic Myelomo... Essential Throm... Hematopoietic a... Hodgkin Lymphom... Myelodysplastic... Myelofibrosis Myeloid Leukemi... Myeloid Neoplas... Non-Hodgkin Lym... Plasma Cell Mye... Polycythemia Ve... Small Lymphocyt... | Hematopoietic C... Mycophenolate M... Tacrolimus Cyclophosphamid... Total-Body Irra... Donor Lymphocyt... Fludarabine Melphalan | 18 Years - | Thomas Jefferson University | |
| Venetoclax and CLAG-M for the Treatment of Acute Myeloid Leukemia and High-Grade Myeloid Neoplasms | NCT04797767 | Acute Biphenoty... Acute Myeloid L... Mixed Phenotype... Myeloid Neoplas... Relapsed Acute ... Relapsed Acute ... Relapsed Mixed ... Relapsed Myeloi... Refractory Acut... Refractory Acut... Refractory Mixe... Refractory Myel... Recurrent Myelo... | Cladribine Cytarabine Mitoxantrone Recombinant Gra... Venetoclax | 18 Years - | University of Washington | |
| Higher or Lower Dose Cladribine, Cytarabine, and Mitoxantrone in Treating Medically Less Fit Patients With Newly Diagnosed Acute Myeloid Leukemia or Myeloid Neoplasm | NCT03012672 | Acute Leukemia ... Acute Myeloid L... Myeloid Neoplas... | Cladribine Cytarabine Granulocyte Col... Mitoxantrone Hy... Quality-of-Life... Questionnaire A... | 18 Years - | University of Washington | |
| Chlorhexidine Gluconate Cleansing in Preventing Central Line Associated Bloodstream Infection and Acquisition of Multi-drug Resistant Organisms in Younger Patients With Cancer or Undergoing Donor Stem Cell Transplant | NCT01817075 | Bacterial Infec... Benign Neoplasm Malignant Neopl... Methicillin-Res... Myeloid Neoplas... Recurrent Child... Recurrent Child... | Chlorhexidine G... Laboratory Biom... Mild Soap Skin ... Questionnaire A... | 2 Months - 21 Years | Children's Oncology Group |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
